ERIN CAVALLO: Open Payments
NPI 1124591961 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 8 payments from 5 companies in 2025. Trend: 2023 $679 · 2024 $499 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $140 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
Products named: CAPLYTA, COBENFY, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
